Advances in Care

Latest Episodes:

Expert Experience: Achieving Greater Success in Lung Transplantation Through Access & Innovation Jun 13, 2024

Show notes

The field of lung transplantation is relatively new with widespread lung transplants beginning in the early 1980s. Throughout the last forty years, it is a field that has rapidly evolved with drastic changes in lung allocation, or deciding who will receive the next available lungs for transplantation. Dr. Selim Arcasoy has led the NewYork-Presbyterian and Columbia Lung Transplant Program through these changes since 2001. Thanks to his dedication to improving lung allocation and foundational research, the program has been a catalyst in changing how lung allocation works in New York and beyond. These policies, in conjunction with Dr. Arcasoy's talented team, clinical research and state of the art tools, have led to greater numbers of patients receiving life-saving transplants.

For more information visit nyp.org/Advances

Cracking the Code: Sequencing the Hodgkin Lymphoma Genome to Uncover New Precision Therapies May 30, 2024

Show notes

In 2012, Dr. Lisa Roth had just landed her dream job as a research scientist and attending physician at NewYork-Presbyterian and Weill Cornell Medicine. But her world came to a screeching halt when she discovered a swollen lymph node on her neck, and was soon diagnosed with the exact type of cancer that she had dedicated her career to studying and treating: Hodgkin Lymphoma. After that experience, Dr. Roth was more determined than ever to uncover the biology of this notoriously difficult to study cancer. Dr. Roth, now Director of Pediatric Oncology and Associate Professor in the Departments of Pediatrics, Medicine and Pathology and Laboratory Medicine at NewYork-Presbyterian and Weill Cornell Medicine, tells the story of how she and her team became the first researchers to sequence the entire Hodgkin Lymphoma genome, opening doors for precision and preventative treatment options.

For more information visit nyp.org/Advances

Data Mining: Using Machine Learning for Predictive Neurocritical Care May 16, 2024

Show notes

Monitoring patients with aneurysmal rupture for delayed cerebral ischemia was historically a numbers game. It was difficult for doctors to predict outcomes in the weeks that followed their rupture, so at-risk patients could find themselves under observation in the ICU anywhere from 7 to 21 days. Dr. Soojin Park, Medical Director of Critical Care Data Science and AI at NewYork-Presbyterian/Columbia, knew there had to be a better way to monitor patients and predict outcomes. So, relying on her background in machine learning and leveraging vast amounts of data, Dr. Park developed the potentially game-changing Continuous Monitoring Tool for Delayed Cerebral Ischemia (or COSMIC) score. The score uses machine learning, and basic patient data that can be collected with equipment available at any hospital, to detect signals that more accurately assess risk, allowing doctors to treat each neurocritical patient with targeted care - ultimately improving outcomes and patient experience.

Connecting Cardio & Cancer: Mitigating Cardiotoxicity with Optimized Treatment Strategies May 02, 2024

Show notes

As methods for early cancer detection improve and the number of cancer survivors rises, the innovative field of cardio-oncology has emerged to ensure that patients with chemotherapy or cancer-related cardiac dysfunction can be safely, and swiftly, treated for their cancer. Dr. Stephanie Feldman, a clinical cardiologist with focus on cardio-oncology at NewYork-Presbyterian/Weill Cornell Medicine, is one of a growing number of physicians advancing research and pushing care in this field forward with a multi-disciplinary, comprehensive approach to care. Dr. Feldman joins us to discuss the rare risks of immune checkpoint inhibitors, how genetic mutations could put patients at risk for arterial thromboembolism, and how the cardio-oncology field can optimize the course of cancer care for patients at risk for cardiovascular complications.

For more information visit nyp.org/Advances

The Surgical Robot: Advancing Medicine with Robot-Assisted Technology Apr 18, 2024

Show notes

With perspectives spanning hepatobiliary, gynecologic, and cardiac surgeries, NewYork-Presbyterian’s Dr. Jason Hawksworth (Columbia), Dr. Tamatha Fenster (Weill Cornell Medicine), and Dr. Arnar Geirsson (Columbia) describe how they each came to incorporate robotics into their practices. One of the biggest takeaways: robotic surgeries allow for more accuracy in minimally-invasive approaches; so patients experience shorter hospital stays and quicker recoveries, even after major procedures. But there are some limitations to robotic surgeries that the doctors are still navigating. Dr. Fenster discusses how there are haptics limitations in robotic surgery. As a result, she shares more about her innovative smartHER 3D MRI program that is addressing this issue and details how her and her team are developing a way of holographically projecting 3D MRIs over patients to help guide surgeons while they operate.

For more information visit nyp.org/Advances

Joint Effort: A Collaborative Surgery Revolutionizing Hip Preservation Apr 04, 2024

Show notes

Dr. Christian and Dr. Van de Velde’s backgrounds are a complementary combination. At their clinic, they see, diagnose, and determine treatment for their patients together. Dr. Christian takes on minimally invasive procedures, utilizing arthroscopy to address extra bone growth that can limit range of motion and can lead to labral tears. Dr. Van de Velde specializes in a more invasive type of surgery: periacetabular Ganz osteotomy. In complex cases, the two surgeons combine for a full-day surgery, where they each use their specialized surgical approach. Through their unique collaboration, the duo is able to provide optimal treatment for their patients, and help to preserve their hip function for as long as possible.

For more information visit nyp.org/Advances

Reimagining Research: Enhancing Cardiac Care for Underrepresented Populations Mar 21, 2024

Show notes

Dr. Mario Gaudino is a cardiac surgeon at NewYork-Presbyterian/Weill Cornell Medicine and the Director of the Joint Clinical Trials Office at Weill Cornell Medicine. There he oversees ongoing improvement and enhancements to existing clinical infrastructure and is currently leading research on the effects of coronary artery bypass surgery on women and people of color. His work not only focuses on groups that have been historically underrepresented in research, it also takes a patient centric approach to outcomes focusing on how a patient feels in addition to clinical metrics. His research contributions have potential to change how doctors approach treating huge swaths of their patient population and how they analyze that data.

Delivering Transformation: Reducing Maternal Mortality through Systemic Change Mar 07, 2024

Show notes

It has been widely reported over the past ten to fifteen years that maternal mortality and morbidity in the US is on the rise. Dr. Dena Goffman has made it her personal goal to improve those numbers across the entire NewYork-Presbyterian health system. But how can one begin to tackle such a large and challenging issue? Dr. Goffman focuses on systematic shifts. She worked to set obstetrics goals across the entire hospital system, created new guidelines and utilized simulations to train and improve the skills of healthcare workers to be prepared for any situation. And she wasn’t afraid to use every tool in her toolbox, even new ones like an ingenious anti-hemorrhage device that she helped gain FDA approval. In this episode, Dr. Goffman shares what real systemic change for maternal fetal care looks like and how she is hoping these standards can help reverse the trends in maternal mortality across the country.

A Move to Minimal: Improving Recovery with Less Invasive Spine Surgery Feb 22, 2024

Show notes

As a doctor trained in both minimally invasive and open approach surgery, Dr. Chan is very familiar with comprehensive spinal care. But there are aspects of minimally invasive surgery that, when possible, position it as preferable for postoperative recovery, namely when it comes to pain. Open surgeries can have patients taking opioids for weeks or even months after their procedure. With minimally invasive spinal surgery, patients may only need opioid pain management for two days postoperatively–or none at all. Motivated by postoperative quality of life, Dr. Chan has fine-tuned several innovative surgical approaches, proving that a surgeon doesn’t necessarily have to perform large muscle dissections in order to correct spinal deformities like scoliosis. His techniques provide surgical opportunities for patients who otherwise would not be spinal surgery candidates due to age or illness. In this episode, Dr. Chan details how he customizes care for his various patients depending on their needs, and shares his hopes for the future of spinal surgery.

For more information visit nyp.org/Advances

The Network Effect: Analyzing Brain Structures to Treat Depression Feb 08, 2024

Show notes

For any patient diagnosed with depression for the first time, the recommended course of treatment is the same: a medication like a selective serotonin reuptake inhibitor (SSRI), an evidence based psychotherapy, or both. But there is a large group of people for whom these treatments simply won't work. That’s where Dr. Conor Liston and his team focus. His work mapping the brain is helping doctors better understand where depression is impacting certain brain structures and what that means for the symptoms patients present. Dr. Liston’s work is focused on identifying how these symptoms impact patients' brains and using those findings to identify the best treatment approach. It also may eventually help detect the likelihood of depression in patients before they exhibit any symptoms.

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected

Our TOPPODCAST Picks

Follow Us

Stay Connected

Advances in Care

Related Podcasts

1

2

3

4

5

6